BREAKING NEWS

AG Hawley Announces Fraud Victims May Seek Compensation from Western Union Fund


Jefferson City, Mo. (November 15, 2017) – Missouri Attorney General Josh Hawley today announced that Missourians who were deceived into sending payments to scammers using Western Union’s wire transfer service may now apply for compensation from a $586 million fund administered by the Department of Justice’s Victim Asset Recovery Program. This fund is a result of a settlement between Missouri, 49 other states, the District of Columbia, and Western Union that was announced in January 2017. Missourians may be eligible to receive compensation if they were a victim of a fraud-induced transfer using Western Union between January 1, 2004 and January 19, 2017. Read more...

AG Hawley Issues Investigative Demands to Google, Inc.


Jefferson City, Mo. (November 13, 2017) – Missouri Attorney General Josh Hawley announced today that his Office has issued an investigative subpoena to Internet giant Google, Inc., in connection with an investigation into the company’s business practices. Specifically, the investigation will seek to determine if Google has violated the Missouri Merchandising Practices Act—Missouri’s principal consumer-protection statute—and Missouri’s antitrust laws.  Read more...

AG Hawley Announces Rape Kit Backlog Investigation


Jefferson City, Mo. (November 9, 2017) –  Missouri Attorney General Josh Hawley today announced his office will conduct a thorough audit of the reported backlog of unprocessed rape kits across the state.“Rape kits provide a powerful tool for identifying and prosecuting potential sex criminals. But both in Missouri and across the country, thousands of rape kits go untested, hamstringing law enforcement efforts to prosecute offenders,” Hawley said. Read more...

AG Hawley Expands Multistate Complaint in Federal Generic Drug Antitrust Lawsuit


Jefferson City, Mo. (November 8, 2017) – Missouri Attorney General Josh Hawley, along with 45 state attorneys general taking part in a wide-ranging multistate antitrust investigation of the generic drug industry, has asked the federal court for permission to file an amended complaint in the states' pending lawsuit that increases the number of generic drug manufacturer defendants from six to eighteen in the case and the number of drugs at issue in the litigation from two to fifteen. For the first time, the states are also suing senior executives at two generic drug companies who are alleged to have engaged in the illegal conduct. Read more...